FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to oncology, and can be used for treating non-small cell lung cancer (NSCLC). Method is carried out by administering to a patient a) an effective amount of composition containing nanoparticles containing paclitaxel and albumin, and b) an agent based on platinum for making a combination drug for treating NSCLC.
EFFECT: invention provides treatment of NSCLC, which is squamous carcinoma.
25 cl, 4 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR BLADDER CANCER TREATMENT | 2011 |
|
RU2621640C2 |
| COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY | 2006 |
|
RU2452482C2 |
| COMBINATIONS AND METHODS FOR THERAPEUTIC AGENTS INTRODUCTION AND COMBINED THERAPY | 2012 |
|
RU2632103C2 |
| COMBINATIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY | 2013 |
|
RU2673805C2 |
| METHOD FOR TREATMENT OF MALIGNANT NEOPLASM, USING COMBINATION OF ANTIBODY TO PD-1 AND CHEMOTHERAPEUTIC AGENT | 2021 |
|
RU2787457C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT | 2008 |
|
RU2483714C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | 2013 |
|
RU2678448C2 |
| METHODS OF TREATING PANCREATIC CANCER | 2011 |
|
RU2576609C2 |
| METHODS FOR COMBINATION THERAPY OF PROLIFERATIVE DISEASES | 2011 |
|
RU2577278C2 |
| APPLICATION OF ERIBULIN IN CANCER TREATMENT | 2015 |
|
RU2699545C2 |
